The skincare and home fragrance company lifted first-half operating profit 34% to $24.2million and maintained its earnings guidance for the full year.
Reported profit rose to $3.5million, or 5c per share, in the period, from $3.2million, or 5cps, a year earlier, the Auckland-based company said in a statement.
Revenue rose 63% to $47.8million. The board did not declare an interim dividend.
Craigs Investment Partners broker Chris Timms said the result was not a surprise and he did not expect to make any significant changes to his forecasts and valuation.
''We believe the stock is appealing at current levels, considering the firm's strong growth prospects.''
Trilogy's brands include Ecoya, Trilogy and Goodness, and it owns CS & Co, the country's largest independent importer and distributor of fragrances and toiletries, which it bought in August 2015.
The company affirmed its September guidance for 2017 revenue of $100million to $110million, a gain of between 20% and 32% on 2016's $83million of sales, and operating profit of $19million to $21million, from $16.3million in 2016.
If Trilogy International achieved $100million in revenue, it would have almost tripled sales in just two years, mainly through the CS & Co acquisition. CS & Co delivered $24million in revenue in the first half, and a profit of $3.6million.
Ecoya delivered nearly $9million in revenue, up 4.4% from the first half of 2016, and $339,000 in profit, while its skincare brands Trilogy and Goodness posted $17.8million in revenue, up 14.6%, although profit fell to $4.5million from $5.5million the previous year.
The bulk of Trilogy's sales still came from New Zealand, at $28.4million in the first half, while $13.5million in revenue came from Australia.
The company said it was working to strengthen its distribution networks and had signed an agreement with a broker and specialist beauty chain Credo Beauty in the US, along with an agreement with Chinese e-commerce company QBID to build its cross-border sales into China.
In May, Trilogy acquired 25% of Chilean rosehip producer Forestal Casino for $US8million ($NZ11.3million) in cash and shares, giving it certainty of supply for an oil used in skincare products. In the first half it gained $183,000 from its share of earnings.
Trilogy shares last traded at $3.66, up 1.4% and have gained 30% this year.
- Additional reporting BusinessDesk
